JAMA. 2026 Jan 20;335(3):255-266. doi: 10.1001/jama.2025.19400.
PMID:41247746
TRPA1 modulation by Sigma-1 receptor prevents oxaliplatin-induced painful peripheral neuropathy.
Marcotti A, Fernández-Trillo J, González A, Vizcaíno-Escoto M, Ros-Arlanzón P, Romero L, Vela JM, Gomis A, Viana F, de la Peña E.
Brain. 2023 Feb 13;146(2):475-491. doi: 10.1093/brain/awac273.
PMID:35871491
Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial.
Smith EM, Pang H, Cirrincione C, Fleishman S, Paskett ED, Ahles T, Bressler LR, Fadul CE, Knox C, Le-Lindqwister N, Gilman PB, Shapiro CL; Alliance for Clinical Trials in Oncology.
Peripheral Neuropathy in Diabetes Mellitus: Pathogenetic Mechanisms and Diagnostic Options.
Galiero R, Caturano A, Vetrano E, Beccia D, Brin C, Alfano M, Di Salvo J, Epifani R, Piacevole A, Tagliaferri G, Rocco M, Iadicicco I, Docimo G, Rinaldi L, Sardu C, Salvatore T, Marfella R, Sasso FC.
Int J Mol Sci. 2023 Feb 10;24(4):3554. doi: 10.3390/ijms24043554.
PMID:36834971
Pathogenesis, diagnosis and clinical management of diabetic sensorimotor peripheral neuropathy.